Drug
Dihydrexidine clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2011
How studies write it
Studies that test it under each name
Studies by the year they started
2 studies that test it; most in 2011 (1)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
Antonia New (1) · National Institute on Drug Abuse (NIDA) (1) · Larry J. Siever (1)
Related medicines
As reviewed, each with the page that says it.
- One of Dopamine Agonists source
Studies
Open first, then newest update. How each study uses dihydrexidine is read from its arms, and is right about nine times in ten.
Testing it · 3
- A D1 Agonist For Working MemoryCompletedPhase 2Antonia NewNCT02507206Written as DAR 0-100A
- Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13Status unknownPhase 1National Institute on Drug Abuse (NIDA)NCT00000348Written as Dihydrexidine
- Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality DisorderStatus unknownPhase 2Larry J. SieverNCT01466205Written as DAR-0100A
Codes
What other systems call dihydrexidine · ClinicalTrials.gg INT003465
- MeSH (NLM) C061532dihydrexidineConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 32D64VH037DIHYDREXIDINEConfirmed NLM, Wikidata
- UNII (FDA) U4MPC92UC2DIHYDREXIDINE, (-)-One source Wikidata
- Wikidata Q5276413DihydrexidineConfirmed NLM, Wikidata
- DrugBank DB12890One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C061532 | dihydrexidine | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 32D64VH037 | DIHYDREXIDINE | Confirmed NLM, Wikidata |
| UNII (FDA) | U4MPC92UC2 | DIHYDREXIDINE, (-)- | One source Wikidata |
| Wikidata | Q5276413 | Dihydrexidine | Confirmed NLM, Wikidata |
| DrugBank | DB12890 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.